|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Stock-based compensation expense | |||||
| Amortization of discount on convertible notes | |||||
| Bad debt expense | |||||
| Deferred income taxes | |||||
| Deferred tax assets valuation allowance release | |||||
| Deferred tax assets establishment related to intra-entity transfers of intangible assets | |||||
| Deferred tax assets valuation allowance establishment | |||||
| Impairment (gain) on investments in privately-held companies | |||||
| Other adjustments | |||||
| Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other assets | |||||
| Operating lease right-of-use assets | |||||
| Accounts payable | |||||
| Accrued and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property and equipment | |||||
| Proceeds from sales of property and equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Purchases of investments in privately-held companies | |||||
| Proceeds from sales of long-lived assets | |||||
| Investments in Finance Justice Fund | |||||
| Business combinations, net of cash acquired | |||||
| Other investing activities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of convertible notes | |||||
| Proceeds from issuance of senior notes | |||||
| Purchases of convertible note hedges | |||||
| Proceeds from issuance of warrants concurrent with note hedges | |||||
| Debt issuance costs | |||||
| Repayment of convertible notes | |||||
| Repurchases of common stock | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Payments of finance lease obligations | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuances of common stock under employee stock purchase plan | |||||
| Cash and cash equivalents | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Foreign exchange effect on cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental cash flow data | |||||
| Interest paid in cash | |||||
| Income taxes paid in cash | |||||
| Supplemental disclosures of non-cash investing and financing activities | |||||
| Common stock issued in connection with acquisitions | |||||
| Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | |||||
| Changes in accrued property and equipment purchases | |||||
| Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flows | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in prepaid expenses and other current assets | |||||
| Restricted cash included in other assets | |||||
Loading...